Ilia I. Ouspenski

Array ( [id] => 8385680 [patent_doc_number] => 08263073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Anti-CTLA-4 antibodies with reduced blocking of binding of CTLA-4 to B7 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/866149 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 44330 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234901 [patent_doc_number] => 20100266605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF A CD28 BINDING PHARMACEUTICAL SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT' [patent_app_type] => utility [patent_app_number] => 12/364395 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7599 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266605.pdf [firstpage_image] =>[orig_patent_app_number] => 12364395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504509 [patent_doc_number] => 20100260779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'METHODS AND MOLECULES FOR MODULATING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/362007 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22040 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260779.pdf [firstpage_image] =>[orig_patent_app_number] => 12362007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062149 [patent_doc_number] => 20110200591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'PRODUCTS AND METHODS TO PREVENT INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/863745 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27473 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200591.pdf [firstpage_image] =>[orig_patent_app_number] => 12863745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532978 [patent_doc_number] => 20090232766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Compositions for Inducing Immune Response Comprising Inverted Microsomes' [patent_app_type] => utility [patent_app_number] => 12/357535 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15257 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232766.pdf [firstpage_image] =>[orig_patent_app_number] => 12357535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062149 [patent_doc_number] => 20110200591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'PRODUCTS AND METHODS TO PREVENT INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/863745 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27473 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200591.pdf [firstpage_image] =>[orig_patent_app_number] => 12863745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664621 [patent_doc_number] => 08378082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Anti-CD86 antibody' [patent_app_type] => utility [patent_app_number] => 12/319442 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8316 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12319442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644255 [patent_doc_number] => 08021860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/318679 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6074 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/021/08021860.pdf [firstpage_image] =>[orig_patent_app_number] => 12318679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477254 [patent_doc_number] => 20100285039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'B7-H1 (CD274) Antagonists Induce Apoptosis of Tumor Cells' [patent_app_type] => utility [patent_app_number] => 12/811604 [patent_app_country] => US [patent_app_date] => 2009-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16518 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285039.pdf [firstpage_image] =>[orig_patent_app_number] => 12811604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007040 [patent_doc_number] => 20110059071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'USE OF CD28-SPECIFIC MONOCLONAL ANTIBODIES FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TREATING VIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/348144 [patent_app_country] => US [patent_app_date] => 2009-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8623 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059071.pdf [firstpage_image] =>[orig_patent_app_number] => 12348144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484901 [patent_doc_number] => 20090274666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE' [patent_app_type] => utility [patent_app_number] => 12/347492 [patent_app_country] => US [patent_app_date] => 2008-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 17594 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274666.pdf [firstpage_image] =>[orig_patent_app_number] => 12347492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514254 [patent_doc_number] => 20090214560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/332944 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23034 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214560.pdf [firstpage_image] =>[orig_patent_app_number] => 12332944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412355 [patent_doc_number] => 20100166740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Anti-OX40L antibodies' [patent_app_type] => utility [patent_app_number] => 12/315863 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22803 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166740.pdf [firstpage_image] =>[orig_patent_app_number] => 12315863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125177 [patent_doc_number] => 20110085970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'ANTI-B7H4 MONOCLONAL ANTIBODY-DRUG CONJUGATE AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/745677 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 58229 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20110085970.pdf [firstpage_image] =>[orig_patent_app_number] => 12745677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473029 [patent_doc_number] => 20090246195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'ANTI-CD19 ANTIBODY THERAPY FOR TRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 12/275545 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 64595 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246195.pdf [firstpage_image] =>[orig_patent_app_number] => 12275545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477609 [patent_doc_number] => 20100041602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules' [patent_app_type] => utility [patent_app_number] => 12/313342 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33318 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041602.pdf [firstpage_image] =>[orig_patent_app_number] => 12313342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452156 [patent_doc_number] => 20090068193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Treatment And Prophylaxis With 4-1BB-Binding Agents' [patent_app_type] => utility [patent_app_number] => 12/269462 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12082 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068193.pdf [firstpage_image] =>[orig_patent_app_number] => 12269462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508022 [patent_doc_number] => 20090081229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'ANTI-PRO87299 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/269710 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 47561 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081229.pdf [firstpage_image] =>[orig_patent_app_number] => 12269710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618764 [patent_doc_number] => 07998478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Pharmaceutical composition for treating immune diseases' [patent_app_type] => utility [patent_app_number] => 12/268832 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 105 [patent_no_of_words] => 28221 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998478.pdf [firstpage_image] =>[orig_patent_app_number] => 12268832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545003 [patent_doc_number] => 08052972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Remedies for inflammatory bowel diseases' [patent_app_type] => utility [patent_app_number] => 12/268882 [patent_app_country] => US [patent_app_date] => 2008-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13692 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/052/08052972.pdf [firstpage_image] =>[orig_patent_app_number] => 12268882 [rel_patent_id] =>[rel_patent_doc_number] =>)